Vasopressin surrogate marker copeptin as a potential novel endocrine biomarker for antidepressant treatment response in major depression: A pilot study

INTRODUCTION: Major depressive disorder (MDD) constitutes the leading cause of disability worldwide. Although efficacious antidepressant pharmacotherapies exist for MDD, only about 40-60% of the patients respond to initial treatment. However, there is still a lack of robustly established and applica...

Descripción completa

Detalles Bibliográficos
Autores principales: Agorastos, A., Sommer, A., Wiedemann, K., Demiralay, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470906/
http://dx.doi.org/10.1192/j.eurpsy.2021.1213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470906/
http://dx.doi.org/10.1192/j.eurpsy.2021.1213

Ejemplares similares